TECSYS Inc. J (TCS) AI Stock Analysis

• Market Cap: C$374.05M
• Dividend Yield: 1.07%
• Average Volume (3M): 45.55K
• Price to Earnings (P/E): 74.4
• Beta (1Y): 0.65
• Revenue Growth: 7.00%
• EPS Growth: 110.62%
• Country: CA
• Employees: 655
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.12
• Shares Outstanding: 14,639,829
• 10 Day Avg. Volume: 18,908
• 30 Day Avg. Volume: 45,554
• PEG Ratio: -41.72
• Price to Book (P/B): 8.06
• Price to Sales (P/S): 3.22
• P/FCF Ratio: 169.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$28.75
• Price Target Upside: -7.91% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2
• EPS Forecast (FY): 0.4
• Revenue Forecast (FY): C$192.63M

• Rating: 64 Neutral
• Price Target: C$28.00 ▼(-10.31% Downside)
• Action: Reiterated Date: 03/05/26
• Date: Action: Reiterated 03/05/26

The score is driven primarily by solid financial stability and a strong earnings-call outlook with reaffirmed growth and margin guidance. This is offset by a weak valuation (high P/E) and only mixed technicals, with the stock still below key longer-term moving averages.

Positive Factors

SaaS ARR & Revenue Growth

Sustained SaaS ARR and recurring revenue growth indicate a durable shift to subscription economics. Higher ARR improves revenue visibility, increases customer lifetime value and creates a compounding base for upsells, supporting multi-quarter organic growth and platform stickiness.

Margin Expansion & Operating Leverage

Record adjusted EBITDA and improving gross margin reflect scalable unit economics as SaaS mix grows. Margin expansion demonstrates durable operating leverage and cost discipline, enabling reinvestment in product and sales while improving long-term free cash generation prospects.

Strong Balance Sheet

Substantial cash with no debt and minimal leverage provides financial flexibility to fund R&D, execute strategic investments, absorb short-term shocks or pursue tuck-in M&A. A conservative balance sheet underpins resilience and reduces refinancing or liquidity risk over the next several quarters.

Negative Factors

Low Net Profitability & FCF Drift

Despite healthy gross margins, low net margin and declining free cash flow growth constrain the company's ability to self-fund growth and increase shareholder returns. Persistent low profitability can limit reinvestment capacity and make the business more sensitive to cost or demand shocks.

Services Backlog Weakness

A meaningful decline in professional services backlog reduces near-term revenue conversion and slows on-site migrations that drive SaaS expansion and stickiness. If services cadence lags, cross-sell, implementation-driven ARR growth and recurring renewals may be pressured over multiple quarters.

Delayed AI Adoption Timeline

Commercial launch of an AI product is structural, but delayed customer adoption means anticipated ARR and stickiness gains may materialize slowly. Investment and sales effort up front may pressure margins before durable revenue benefits from TecsysIQ are realized over coming quarters.

TECSYS Inc. J Business Overview & Revenue Model

Company Description

Tecsys Inc. engages in the development, marketing, and sale of enterprise-wide supply chain management software and related services in Canada, the United States, Europe, and internationally. The company offers warehouse management, distribution and transportation management, supply management at point-of-use and order management and fulfillment, as well as financial management and analytics solutions. It also provides implementation, system enhancement, cloud, advisory, consulting, education, training, and maintenance and support services, as well as engages in sale of hardware. The company primarily serves the healthcare systems, automotive and services parts, third-party logistics, retail, and general wholesale distribution industries. Tecsys Inc. was incorporated in 1983 and is headquartered in Montreal, Canada.

How the Company Makes Money

TECSYS generates revenue primarily through the sale of its software solutions and related services. The company operates on a subscription-based model, where clients pay recurring fees for access to its software, including cloud-based services. Additionally, TECSYS earns revenue from professional services such as implementation, training, and ongoing support. Key revenue streams include licenses for proprietary software, maintenance agreements, and consulting services. The company also benefits from strategic partnerships with technology providers and distributors, which enhance its market reach and expand its customer base, contributing significantly to its earnings.

TECSYS Inc. J Financial Statement Overview

Summary

Solid fundamentals supported by strong gross margin (49.48% TTM) and an exceptionally low debt-to-equity ratio (0.009 TTM). Offsetting factors include low net margin (2.46% TTM) and negative free cash flow growth (-10.68% TTM), which temper overall quality.

Income Statement

TECSYS Inc. shows a solid revenue growth rate of 3.44% TTM, indicating a positive trajectory in sales. The gross profit margin of 49.48% TTM is strong, reflecting efficient cost management. However, the net profit margin is relatively low at 2.46% TTM, suggesting room for improvement in profitability. The EBIT and EBITDA margins are moderate at 4.25% and 6.36% TTM, respectively, indicating stable operational performance.

Balance Sheet

The company maintains a very low debt-to-equity ratio of 0.009 TTM, highlighting minimal leverage and financial stability. The return on equity is modest at 6.63% TTM, suggesting efficient use of equity capital. The equity ratio stands at 51.00% TTM, indicating a strong equity base relative to total assets, which enhances financial resilience.

Cash Flow

Operating cash flow to net income ratio is 2.73 TTM, showing strong cash generation relative to net income. However, the free cash flow growth rate is negative at -10.68% TTM, indicating a decline in cash available for reinvestment. The free cash flow to net income ratio is 0.63 TTM, suggesting that a significant portion of earnings is converted into free cash flow.

Breakdown	TTM	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020
Income Statement
Total Revenue	186.34M	176.45M	152.42M	137.20M	123.10M	104.86M
Gross Profit	94.04M	85.29M	66.81M	60.31M	60.63M	50.32M
EBITDA	13.41M	11.06M	7.99M	10.11M	15.26M	8.73M
Net Income	5.43M	4.46M	2.09M	4.48M	7.19M	2.35M
Balance Sheet
Total Assets	133.71M	140.41M	126.92M	125.84M	129.31M	124.43M
Cash, Cash Equivalents and Short-Term Investments	30.47M	39.29M	37.07M	43.24M	45.85M	37.53M
Total Debt	437.00K	1.32M	2.91M	14.24M	18.76M	20.91M
Total Liabilities	65.54M	69.15M	56.48M	57.16M	62.22M	63.31M
Stockholders Equity	68.17M	71.26M	70.44M	68.68M	67.09M	61.12M
Cash Flow
Free Cash Flow	8.53M	11.16M	5.97M	2.88M	17.58M	8.88M
Operating Cash Flow	14.84M	13.91M	7.76M	4.94M	19.11M	10.01M
Investing Cash Flow	-5.35M	2.89M	-1.11M	-2.38M	-13.75M	-13.25M
Financing Cash Flow	-7.77M	-8.07M	-8.42M	-5.31M	-7.14M	15.86M

TECSYS Inc. J Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 31.22
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:TCS, the sentiment is Negative. The current price of 31.22 is above the 20-day moving average (MA) of 24.57, above the 50-day MA of 27.27, and below the 200-day MA of 34.24, indicating a neutral trend. The MACD of -0.47 indicates Negative momentum. The RSI at 53.68 is Neutral, neither overbought nor oversold. The STOCH value of 80.83 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:TCS.

TECSYS Inc. J Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DSG	72 Outperform	C$8.00B	43.26	10.70%	―	14.55%	15.55%
DCBO	72 Outperform	C$721.70M	16.69	56.90%	―	16.25%	31.71%
ENGH	69 Neutral	C$980.11M	15.58	12.20%	5.69%	-0.72%	-9.27%
KXS	67 Neutral	C$3.69B	54.72	8.24%	―	15.11%	75.40%
TCS	64 Neutral	C$374.05M	74.37	8.14%	1.07%	7.00%	110.62%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
OTEX	59 Neutral	C$8.57B	12.20	10.55%	3.27%	-5.01%	13.21%

TECSYS Inc. J Corporate Events

Tecsys Delivers Record Q3 Results, Launches AI Platform and Cuts Jobs to Boost Efficiency

Tecsys reported a strong third quarter of fiscal 2026, posting record SaaS revenue of $20.1 million and record Adjusted EBITDA of $5.0 million, up 17% and 43% respectively from a year earlier. Total revenue rose to $48.5 million, net profit improved to $1.7 million, and SaaS metrics such as ARR and remaining performance obligations showed double-digit growth, underpinned by the largest Q3 bookings in the company’s history.

The quarter also saw the commercial launch of TecsysIQ, an AI intelligence layer designed to unify data and enable autonomous supply chain execution, which management says will amplify the value of its core platforms. Subsequent to quarter-end, Tecsys implemented a 7% workforce reduction expected to deliver annualized cost savings of about $8.1 million, while maintaining full-year fiscal 2026 guidance and continuing capital returns through share repurchases and a quarterly dividend of $0.09 per share.

The most recent analyst rating on (TSE:TCS) stock is a Hold with a C$28.50 price target. To see the full list of analyst forecasts on TECSYS Inc. J stock, see the TSE:TCS Stock Forecast page.

Tecsys Wins Modern Healthcare Best in Business Award for Supply Chain Excellence

Tecsys Inc., a specialist in healthcare-focused supply chain software for functions such as pharmacy inventory management, point-of-use tracking and real-time analytics, has been named a winner in Modern Healthcare’s 2025 Best in Business Awards for supply chain excellence. The recognition underscores Tecsys’s role in shoring up supply chain resilience and visibility for major health systems, helping hospitals ensure critical products are available when and where needed and addressing industry challenges like drug shortages and fragmented demand planning, thereby strengthening its positioning as a key technology partner to leading U.S. health networks and reinforcing investor confidence in its healthcare growth strategy.

The most recent analyst rating on (TSE:TCS) stock is a Hold with a C$32.00 price target. To see the full list of analyst forecasts on TECSYS Inc. J stock, see the TSE:TCS Stock Forecast page.